Scott Gottlieb
Scott Gottlieb is a physician and public health expert who served as the 23rd Commissioner of the Food and Drug Administration (FDA) from 2017 to 2019.
He has extensive experience in healthcare policy and regulation, having worked in various roles within the FDA and Department of Health and Human Services.
Gottlieb is known for his work on drug approvals, tobacco regulation, and addressing the opioid crisis.
He is a resident fellow at the American Enterprise Institute and serves on the board of Pfizer.
Gottlieb is a frequent commentator on healthcare issues and has written for various publications.
His expertise in public health and government operations provides a unique perspective on the COVID-19 pandemic response.
